Y. Issa-Nummer

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab – a translational project in the neoadjuvant GeparQuinto trial

P. Fasching, T. Fehm, S. Loibl, 2011, British Journal of Cancer.

Tumor-infiltrating lymphocytes in breast cancer

C. Denkert, S. Loibl, G. von Minckwitz, 2014, Oncoimmunology.

Prospective Validation of Immunological Infiltrate for Prediction of Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer – A Substudy of the Neoadjuvant GeparQuinto Trial

Carsten Denkert, Manfred Dietel, C. Denkert, 2013, PloS one.